Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

Clinical trial NCT00906399 · COMPLETED

Trial details

NCT number: NCT00906399
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2009-06-01
Primary completion: 2012-10-01
Enrollment: 1516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.